China Resources Pharmaceutical Group Limited Share Price
Stocks
3320
HK0000311099
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
01:38:29 17/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 4.850 HKD | +0.10% |
|
+0.21% | +8.99% |
| 29/07 | China Resources Pharmaceutical Holdings Company Limited Completes Issue of Second Tranche of Medium Term Notes 2026 in the Prc | CI |
| 22/07 | China Resources Pharma Unit Sells 1 Billion Yuan Bonds | MT |
| Market Cap | 3.05TCr 388.39Cr 335.3Cr 314.56Cr 286.51Cr 538.72Cr 37TCr 546.19Cr 3.69TCr 1.45TCr 19TCr 1.46TCr 1.43TCr 62TCr | P/E 2026 * |
6.14x | P/E 2027 * | 5.75x |
|---|---|---|---|---|---|
| Enterprise Value | 8.47TCr 1.08TCr 931.84Cr 874.22Cr 796.25Cr 1.5TCr 1,03200Cr 1.52TCr 10TCr 4.02TCr 52TCr 4.05TCr 3.96TCr 1,72000Cr | EV / Sales 2026 * |
0.26x | EV / Sales 2027 * | 0.23x |
| Free-Float |
29.17% | Yield 2026 * |
4.28% | Yield 2027 * | 4.67% |
| 1 day | +0.10% | ||
| 1 week | +0.21% | ||
| 1 month | +1.25% | ||
| 3 months | -1.62% | ||
| 6 months | +5.66% | ||
| Current year | +8.99% |
| 1 week | 4.81 |  | 4.95 |
| 1 month | 4.72 | | 4.95 |
| Current year | 4.22 | | 6.53 |
| 1 year | 4.22 | | 6.53 |
| 3 years | 4.22 | | 7.11 |
| 5 years | 3.18 | | 8.13 |
| 10 years | 3.18 | | 13.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Cheng
PSD | President | 47 | 26/08/2025 |
Rong Hui Deng
DFI | Director of Finance/CFO | 54 | 13/06/2023 |
Wing Yi Wan
SEC | Corporate Secretary | - | 15/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ting Mei Fu
BRD | Director/Board Member | 59 | 01/06/2016 |
Ke Jian Zhang
BRD | Director/Board Member | 70 | 20/06/2016 |
Xiao Song Bai
CHM | Chairman | 55 | 29/08/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/04/20 | Other | Chief Executive Officer | 2,00,000 | 0.0032% | ||
| 31/03/20 | Other | Chief Executive Officer | 1,00,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.10% | +0.21% | -8.32% | -14.91% | 387.88Cr | |
| +0.25% | -3.96% | +69.50% | +120.06% | 1,05200Cr | |
| +0.78% | +0.21% | +48.86% | +50.78% | 63TCr | |
| +0.35% | +0.95% | +21.18% | +66.86% | 44TCr | |
| +0.28% | -3.05% | +39.10% | +36.65% | 35TCr | |
| +0.78% | -2.05% | +24.03% | +36.97% | 29TCr | |
| +0.87% | -2.82% | -0.28% | +6.27% | 24TCr | |
| +1.00% | +0.52% | +43.32% | +58.95% | 22TCr | |
| -0.78% | -4.16% | -10.28% | -53.87% | 20TCr | |
| +0.40% | +4.40% | +17.74% | +81.59% | 17TCr | |
| Average | +0.16% | -0.68% | +24.49% | +38.94% | 35.99TCr | |
| Weighted average by Cap. | +0.27% | -0.63% | +40.08% | +63.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33TCr 4.17TCr 3.6TCr 3.38TCr 3.07TCr 5.78TCr 3,98500Cr 5.86TCr 40TCr 16TCr 1,99700Cr 16TCr 15TCr 6,64200Cr | 34TCr 4.38TCr 3.78TCr 3.55TCr 3.23TCr 6.08TCr 4,19000Cr 6.16TCr 42TCr 16TCr 2,09900Cr 16TCr 16TCr 6,98200Cr |
| Net income | 486.06Cr 62Cr 53Cr 50Cr 46Cr 86Cr 5.92TCr 87Cr 588.23Cr 230.51Cr 2.97TCr 232.61Cr 227.57Cr 9.87TCr | 525.88Cr 67Cr 58Cr 54Cr 49Cr 93Cr 6.41TCr 94Cr 636.43Cr 249.39Cr 3.21TCr 251.67Cr 246.22Cr 11TCr |
| Net Debt | 5.42TCr 691.01Cr 596.55Cr 559.65Cr 509.74Cr 958.48Cr 66TCr 971.76Cr 6.56TCr 2.57TCr 33TCr 2.59TCr 2.54TCr 1,10100Cr | 4.87TCr 621.25Cr 536.33Cr 503.16Cr 458.29Cr 861.72Cr 59TCr 873.67Cr 5.9TCr 2.31TCr 30TCr 2.33TCr 2.28TCr 99TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | HK$4.850 | +0.10% | 47,46,500 |
| 14/26/14 | HK$4.845 | -0.92% | 37,52,750 |
| 13/26/13 | HK$4.890 | -0.10% | 62,07,500 |
| 12/26/12 | HK$4.895 | -0.20% | 67,03,250 |
| 11/26/11 | HK$4.905 | +1.13% | 81,07,705 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 3320 Stock
Select your edition
All financial news and data tailored to specific country editions
